153 related articles for article (PubMed ID: 21982569)
1. The role of nucleoside/nucleotide transport and metabolism in the uptake and retention of 3'-fluoro-3'-deoxythymidine in human B-lymphoblast cells.
Plotnik DA; McLaughlin LJ; Chan J; Redmayne-Titley JN; Schwartz JL
Nucl Med Biol; 2011 Oct; 38(7):979-86. PubMed ID: 21982569
[TBL] [Abstract][Full Text] [Related]
2. The effects of 5-fluoruracil treatment on 3'-fluoro-3'-deoxythymidine (FLT) transport and metabolism in proliferating and non-proliferating cultures of human tumor cells.
Plotnik DA; McLaughlin LJ; Krohn KA; Schwartz JL
Nucl Med Biol; 2012 Oct; 39(7):970-6. PubMed ID: 22560972
[TBL] [Abstract][Full Text] [Related]
3. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
Krys D; Hamann I; Wuest M; Wuest F
FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
[TBL] [Abstract][Full Text] [Related]
4. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Plotnik DA; Emerick LE; Krohn KA; Unadkat JD; Schwartz JL
J Nucl Med; 2010 Sep; 51(9):1464-71. PubMed ID: 20720049
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
[TBL] [Abstract][Full Text] [Related]
6. Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo.
Plotnik DA; Asher C; Chu SK; Miyaoka RS; Garwin GG; Johnson BW; Li T; Krohn KA; Schwartz JL
Nucl Med Biol; 2012 Nov; 39(8):1161-6. PubMed ID: 22985987
[TBL] [Abstract][Full Text] [Related]
7. Correlation of 18F-FLT uptake with equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in gastrointestinal cancer.
Kameyama R; Yamamoto Y; Izuishi K; Sano T; Nishiyama Y
Nucl Med Commun; 2011 Jun; 32(6):460-5. PubMed ID: 21423062
[TBL] [Abstract][Full Text] [Related]
8. 17-Allylamino-17-demethoxygeldanamycin-induced Changes in [
Lee HJ; Kim DH; Lee SJ
Anticancer Res; 2017 Jun; 37(6):2993-2999. PubMed ID: 28551637
[TBL] [Abstract][Full Text] [Related]
9. Correlation of 4'-[methyl-
Takami Y; Yamamoto Y; Ueno M; Chiba Y; Norikane T; Hatakeyama T; Miyake K; Toyohara J; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):634-641. PubMed ID: 30039191
[TBL] [Abstract][Full Text] [Related]
10. Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.
Lee EJ; Lee SJ
Oncol Rep; 2013 Feb; 29(2):763-70. PubMed ID: 23232555
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
Lee SJ; Yeo JS; Lee HJ; Lee EJ; Kim SY; Jang SJ; Lee JJ; Ryu JS; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1327-35. PubMed ID: 24562648
[TBL] [Abstract][Full Text] [Related]
12. Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer.
Xi Y; Chen H; Xi Y; Hai W; Qu Q; Zhang M; Li B
Nucl Med Biol; 2023; 120-121():108350. PubMed ID: 37229950
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
[TBL] [Abstract][Full Text] [Related]
14. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
Ashek A; Spruijt OA; Harms HJ; Lammertsma AA; Cupitt J; Dubois O; Wharton J; Dabral S; Pullamsetti SS; Huisman MC; Frings V; Boellaard R; de Man FS; Botros L; Jansen S; Vonk Noordegraaf A; Wilkins MR; Bogaard HJ; Zhao L
Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007402. PubMed ID: 30354494
[TBL] [Abstract][Full Text] [Related]
15. A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.
Guo N; Xie J; Manning HC; Deane NG; Ansari MS; Coffey RJ; Gore J; Price RR; Baldwin RM; McIntyre JO
Mol Imaging Biol; 2011 Apr; 13(2):257-64. PubMed ID: 20532643
[TBL] [Abstract][Full Text] [Related]
16. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
Lee SJ; Kim SY; Chung JH; Oh SJ; Ryu JS; Hong YS; Kim TW; Moon DH
Biochem Pharmacol; 2010 Nov; 80(10):1528-36. PubMed ID: 20723540
[TBL] [Abstract][Full Text] [Related]
17. Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine.
Paproski RJ; Young JD; Cass CE
Biochem Pharmacol; 2010 Feb; 79(4):587-95. PubMed ID: 19788890
[TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of transport and metabolism of 4'-thiothymidine in human tumor cells.
Plotnik DA; Wu S; Linn GR; Yip FCT; Comandante NL; Krohn KA; Toyohara J; Schwartz JL
Nucl Med Biol; 2015 May; 42(5):470-474. PubMed ID: 25659855
[TBL] [Abstract][Full Text] [Related]
19. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
20. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]